The US units of three state-controlled Chinese telecommunications firms have urged the Federal Communications Commission (FCC) not to revoke their authorization to operate in the US.
In April, the FCC issued show-cause orders against US operations of China Telecom, China Unicom, and Pacific Networks Corp, and its subsidiary ComNet (USA).
China Telecom (Americas) called the US government's claims "unfounded" and that its right to operate in the US should not be revoked based solely on foreign policy concerns in the absence of any evidence of specific misconduct.
Meanwhile, China Unicom (Americas) flaunted its two-decade track record of compliance with its FCC regulatory obligations, demonstrated willingness to cooperate with US law enforcement agencies, and as a valuable contributor to US telecommunications markets.
Pacific and ComNet added that neither of them had been asked by the Chinese government to take any action that would jeopardize US national security and law enforcement interests.
According to its chairman Ajit Pai, the FCC had grave concerns about those companies' vulnerability to the exploitation, influence, and control of the Chinese Communist Party.
The Justice Department, Homeland Security, Defense, State, and Commerce Departments says that China Telecom's operations pose substantial and unacceptable national security and law enforcement risks.
The FCC granted approvals to the telcos to operate in the US around two decades ago.


Google to Move All Pixel Production Out of China by 2027
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Shein Targets $26B-$27B Valuation for Hong Kong IPO
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 



